Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period") to visit our website. Doximity operates a digital platform that connects medical professionals, provides medical information, and offers patient schedulin ...

RADNOR, Pa., June 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States Di ...

NEW ORLEANS, May 24, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company's shares between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action is pending in the United States District Court for ...

NEW YORK, May 30, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Doximity and certain of its officers and/ ...

Investors might want to bet on Doximity (DOCS) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a changing ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40508 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-2485512 (State or Other Jurisd ...

New York, May 22, 2024 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the "Class Period"), of the important June 17, 2024 lead plaintiff deadline.SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.WHAT TO DO NE ...

Key PointsDoximity is a leading social media platform used by 80% of doctors and 60% of nurse practitioners and physician assistants nationwide to network, research, collaborate and coordinate patient care.Doximity is becoming the standard tool among hospitals in the United States for finding colleagues, checking calendars and calling patients.Doximity recorded a fiscal Q4 2024 EPS beat of 5 cents on 6.4% revenue growth as it added over 400,000 new medical professionals to its platform in 2024.5 stocks we l ...

NEW ORLEANS, May 17, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company's shares between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District California.Get HelpDoximity inv ...

Key Takeaways Doximity shares jumped Friday morning after the digital medical networking company topped quarterly earnings forecasts, provided a better-than-expected current-quarter outlook, and unveiled a stock buyback program. Subscription revenue in the fiscal fourth quarter was $112.7 million, a 9% increase from a year earlier, helping to boost top-line growth. Monitor the $28 level, an area where the stock may find overhead resistance from a horizontal line connecting a series of price action over the ...